DILLON BRIGGMAN: Open Payments
NPI 1508425323 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $519
Food & beverage: $369Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $163 |
| H2-Pharma, LLC | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Alkermes, Inc. | 2 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: INVEGA SUSTENNA, UZEDY, ARISTADA, ABILIFY MAINTENA, COBENFY.
Industry payments across SC — which companies pay providers there.
